Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children

International Journal of Pediatric Otorhinolaryngology

Volumn 64, Issue 2, 2002, Pages 133-141

  Dhooge, Ingeborg J ^a   Van Kempen, Muriel J P ^a   Sanders, Lieke A M ^b   Rijkers, Ger T ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

IgG2 IgA antibodies; Immunization; Polysaccharide vaccine; Recurrent acute otitis media; Streptococcus pneumoniae

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; PNEUMOCOCCUS VACCINE; PNEUMUNE; POLYSACCHARIDE VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENICITY; INFANT; INFECTION SENSITIVITY; MALE; NASOPHARYNX; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; VACCINATION;

ADENOIDECTOMY; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; MENINGOCOCCAL VACCINES; MIDDLE EAR VENTILATION; OTITIS MEDIA WITH EFFUSION; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; REFERENCE VALUES; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0037124448     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5876(02)00068-X     Document Type: Article

References (35)

1. What is an 'otitis-prone' child?
2. Ten-year review of otitis media pathogens
3. The concept of pronicity in otitis media
4. Immunoglobulin G, total and subclass, in children with or without recurrent otitis media
5. Plasma IgG, IgG subclasses and acute-phase proteins in children with recurrent acute otitis media
6. Pneumococcal antibodies in families with recurrent otitis media
7. Pneumococcal serum antibody concentrations during the first three years of life: A study of otitis-prone and non-otitis-prone children
8. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children
9. Otitis media: The pathogenesis approach. Definitions and terminology
10. Defective anti-polysaccharide antibody response in children with recurrent respiratory tract infections
11. Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections
12. Pneumoccocal polysaccharide vaccine in young adults and older bronchitics: Determination of IgG responses by ELISA and the effect of adsorption of serum with non-specific cell wall polysaccharide
13. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood
14. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S
15. Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF
16. Role of nasopharyngeal bacterial flora in the evaluation of recurrent middle ear infections in children
17. Ontogeny of the immune response as a basis of childhood disease
18. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency
19. Pneumococcal middle ear fluid antibodies after pneumococcal acute otitis media in infants
20. Secretory antibodies specific to Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion during acute otitis media
21. Infant B cell responses to polysaccharide determinants
22. Pneumococcal vaccine and otitis media
23. Prevention of otitis media in children by pneumococcal vaccination
24. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama
25. The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae
26. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage
27. Glycoconjugate vaccines: Future combinations
28. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations
29. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
30. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine
31. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group [see comments]
32. Functional properties of human B cell subpopulations defined by monoclonal antibodies HB4 and FMC7
33. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children
34. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta